Behavioral assessment of atypical antipsychotics in rats: Studies of the effects of olanzapine (Zyprexa)

Psychopharmacology

Volumn 145, Issue 3, 1999, Pages 309-316

  Trevitt, J T ^a   Carlson, B B ^a   Salamone, J D ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Clozapine; Cognex; Extrapyramidal; Motor; Schizophrenia; Tacrine

Indexed keywords

CLOZAPINE; HALOPERIDOL; OLANZAPINE; TACRINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; JAW MOVEMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; JAW; MALE; MOVEMENT; NOOTROPIC AGENTS; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; TACRINE;

EID: 0032802374     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051063     Document Type: Article

References (74)

1. Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA (1993) Clozapine-induced agranulocytosis: incidence and risk factors in the United States. N Engl J Med 329:162-167
2. Arevalo GJ, Gershanik OS (1993) Modulatory effect of clozapine on levodopa response in Parkinson's disease: a preliminary study. Mov Disord 8:349-354
3. Baidessarini RJ, Frankenburg FR (1991) Clozapine: a novel antipsychotic agent. N Engl J Med 324:746-754
4. Baskin P, Salamone JD (1993) Vacuous jaw movements in rat induced by acute reserpine administration: interactions with different doses of apomorphine. Pharmacol Biochem Behav 46:793-797
5. Baskin P, Gianutsos G, Salamone JD (1994) Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding. Pharmacol Biochem Behav 49:437-442
6. Beasley CM, Sanger T, Satterlee W, Tollefson GD, Tran PV, Hamilton S (1996) Olanzapine vs. placebo: results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology 124: 159-167
7. Beasley CM, Tollefson GD, Tran PV (1997a) Efficacy of olanzapine: an overview of pivotal clinical trials. J Clin Psychiatry 58:s7-s12
8. Beasley CM, Tollefson GD, Tran PV (1997b) Safety of olanzapine. J Clin Psychiatry 58:s13-s17
9. Bernardi F, Del Zompo M (1990) Clozapine in idiopathic Parkinson's disease. Neurology 40:1151
10. Bezchlibnyk-Butler KZ, Remington GJ (1994) Antiparkinsonian drugs in the treatment of neuroleptic-induced extrapyramidal symptoms. Can J Psychiatry 39:74-84
11. Bymaster FP, Hemrick-Lueke SK, Pery KW, Fuller RW (1996) Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha1-adrenergic and muscarinic receptors in vivo in rats. Psychopharmacology 124:87-94
12. Bymaster FP, Rasmussen K, Calligaro DO, Nelson DL, DeLapp NW, Wong DT, Moore NA (1997) In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. J Clin Psychiatry 58:s28-s36
13. Capehart BP, Holsinger T (1998) Olanzapine on trial. Am J Psychiatry 155: 152
14. Casey DE (1997) The relationship of pharmacology to side effects. J Clin Psychiatry 58:s55-s62
15. Chesler EJ, Salamone JD (1996) Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements. Pharmacol Biochem Behav 54:619-624
16. Collins P, Broekkamp CLE, Jenner P, Marsden CD (1993) Electromyographic differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat. Psychopharmacology 112:428-436
17. Cousins MS, Salamone JD (1998) Behavioral and electromyographic characterization of the local frequency of tacrine-induced tremulous jaw movements. Physiol Behav 64:153-158
18. Cousins MS, Carriero DL, Salamone JD (1997) Tremulous jaw movements induced by the acetylcholinesterase inhibitor tacrine: effects of antiparkinsonian drugs. Eur J Pharmacol 322:137-145
19. Duvoisin RC (1967) Cholinergic-anticholinergic antagonism in parkinsonism. Arch Neurol 17:124-136
20. Egan MF, Hurd Y, Ferguson J, Bachus SE, Hamid EH, Hyde TM (1996) Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol. Psychopharmacology 127:337-345
21. Factor SA, Friedman JH (1997) The emerging role of clozapine in the treatment of movement disorders. Mov Disord 12:483-496
22. Finn M, Jassen A, Baskin P (1997) Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions. Pharmacol Biochem Behav 57:243-249
23. Fisher PA, Baas H, Hefner R (1990) Treatment of parkinsonian tremor with clozapine. J Neurotransm 2:233-238
24. Friedman JH, Lannon MC (1990) Clozapine-responsive tremor in Parkinson's disease. Mov Disord 5:225-229
25. Friedman JH, Goldstein S, Jacques C (1998) Substituting clozapine for olanzapine in psychiatrically stable Parkinson's disease patients: results of an open label pilot study. Clin Neuropharmacol 21:285-288
26. Fulton B, Goa K (1997) Olanzapine - a review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Drugs 53:281-298
27. Gao XM, Sakai K, Tamminga CA (1998) Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol. Neuropsychopharmacology 19:428-433
28. Gunne LM, Andersson U, Bondesson U, Johansson P (1986) Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol Biochem Behav 25:897-901
29. Harbaugh RE, Roberts DW, Coombs DW, Saunders RL, Reeder TM (1984) Preliminary report: intracranial cholinergic drug infusion in patients with Alzheimer's disease. Neurosurgery 15:514-518
30. Hoffman DC, Donovan H (1995) Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. Psychopharmacology 120:128-133
31. Jicha G, Salamone JD (1991) Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to Parkinsonian symptoms. J Neurosci 11:3822-3829
32. Johansson P, Casey DE, Gunne LM (1986) Dose-dependent increases in rat spontaneous chewing rates during long-term administration of haloperidol but not clozapine. Psychopharmacol Bull 22:1017-1019
33. Kane J, Honigfeld G, Singer J, Meltzer H (1988) Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 45:789-796
34. Kelley AE, Bakshi VP, Delfs JM, Lang CG (1989) Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: pharmacological and regional specificity. Psychopharmacology 99:542-549
35. Keppel G (1982) Design and analysis: a researchers handbook. Prentice Hall, Englewood Cliffs, NJ
36. Marsden CD, Tarsy D, Baldessarini RJ (1975) Spontaneous and drug-induced movement disorders in psychotic patients. In: Bendon DF, Blumer D (eds) Psychiatric aspects of neurological disease. Grune and Stratten, New York, pp 219-266
37. Mayorga AJ, Carriero DL, Cousins MS, Gianutsos G, Salamone JD (1997) Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects. Pharmacol Biochem Behav 56:273-279
38. Mayorga AJ, Cousins MS, Trevitt JT, Conlan A, Gianutsos G, Salamone JD (1999) Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats. Eur J Pharmacol 364:7-11
39. McEvoy JP (1983) The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. J Clin Psychopharmacol 3:288-301
40. Meltzer HY (1989) Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 99:s18-s27
41. Miller RJ, Hiley CR (1974) Anti-muscarinic properties of neuroleptics and drug-induced parkinsonism. Nature 248:596-597
42. Miller DD, Perry PJ, Cadoret RJ, Andreasen NC (1994) Clozapine's effect on negative symptoms in treatment-refractory schizophrenics. Compr Psychiatry 35:8-15
43. Moore NA, Tye NC, Axton MS, Risius FC (1992) The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262:545-551
44. Moore NA, Leander JD, Benvenga MJ, Gleason SD, Shannon H (1997) Behavioral pharmacology of olanzapine: a novel antipsychotic drug. J Clin Psychiatry 58:s37-s44
45. Nawab A (1997) Effects of fluphenazine on lever pressing and tacrine-induced vacuous jaw movements in rats: a study of extrapyramidal side effects (honors thesis). University of Connecticut, USA
46. Noring U, Povlesen UJ, Casey DE, Gerlach J (1984) Effect of a cholinomimetic drug (RS 86) in tardive dyskinesia and drug-related parkinsonism. Psychopharmacology 84:569-571
47. Pakkenberg H, Pakkenberg B (1986) Clozapine in the treatment of tremor. Acta Neurol Scand 73:295-297
48. Pilowski LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundson T, Ell PJ, Nohira V, Kerwin RW (1996) Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine - a 123I IBZM single photome emission tomography study. Psychopharmacology 124:148-153
49. Roth BL, Tandra S, Burgess LH, Sibley DR, Meltzer HY (1995) D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Psychopharmacology 120:365-368
50. Rupniak NMJ, Jenner P, Marsden CD (1983) Cholinergic modulation of perioral behavior induced by chronic neuroleptic administration to rats. Psychopharmacology 79:226-230
51. Rupniak NMJ, Jenner P, Marsden CD (1985) Pharmacological characterization of spontaneous or drug-induced purposeless chewing movements in rats. Psychopharmacology 85:71-79
52. Rupniak NMJ, Jenner P, Marsden CD (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88:403-419
53. Safferman A, Lieberman JA, Kane JM, Szymanski S, Kinon B (1991) Update on the clinical efficacy of clozapine. Schizophr Bull 17:247-261
54. Salamone JD, Baskin PB (1996) Vacuous jaw movements induced by reserpine and low-dose apomorphine: possible model of parkinsonian tremor. Pharmacol Biochem Behav 53:179-183
55. Salamone JD, Lalies MD, Channell SL, Iversen SD (1986) Behavioral and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat. Psychopharmacology 88:467-471
56. Salamone JD, Johnson CJ, McCullough LD, Steinpreis RE (1990) Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat. Psychopharmacology 102:529-534
57. Salamone JD, Cousins MS, Maio C, Champion M, Turski T, Kovach J (1996) Different behavioral effects of haloperidol, clozapine and thioridazine in an instrumental lever pressing/feeding procedure. Psychopharmacology 125:105-112
58. Salamone JD, Mayorga AJ, Trevitt JT, Cousins MS, Conlan A, Nawab A (1998) Tremulous jaw movements in rats: a model of parkinsonian tremor. Prog Neurobiol 56:591-611
59. Schotte A, Janssen PFM, Gommeren W, Luyten WHML, Van Compel P, Lesage AS, De Moore K, Leysen JE (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124:57-73
60. Seeman P, Corvett R, Van Tol HHM (1997) Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors. Neuropsychopharmacology 16:93-110
61. Snyder SH, Banerjee SP, Yamamura HI, Greenberg D (1974) Drugs, neurotransmitters and schizophrenia. Science 184: 1243-1253
62. Stanford JA, Fowler SC (1997) Similarities and differences between the subchronic and withdrawal effects of clozapine on forelimb force steadiness. Psychopharmacology 132:408-414
63. Steinpreis RE, Salamone JD (1993) The effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats. Pharmacol Biochem Behav 46:405-409
64. Steinpreis RE, Baskin PP, Salamone JD (1993) Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine. Psychopharmacology 111:99-105
65. Steinpreis RE, Parret F, Summ R, Panos JJ (1997) Effects of clozapine and haloperidol on baseline levels of vacuous jaw movements in aged rats. Behav Brain Res 86:165-169
66. Stewart B, Rose S, Jenner P, Marsden CD (1987) Pilocarpine-induced puposeless chewing behavior in rats is dependent on intact stores of 5-HT. Eur J Pharmacol 142:173-176
67. Stewart BR, Jenner P, Marsden CD (1988) The pharmacological characterization of pilocarpine-induced chewing in the rat. Psychopharmacology 97:228-234
68. Strauss AJ, Bailey RK, Dralle PW, Eschmann AJ, Wagner RB (1998) Conventional psychotropic-induced tremor extinguished by olanzapine. Am J Psychiatry 155:1132
69. Tarsy D (1983) Neuroleptic-induced extrapyramidal reactions: classification, description and diagnosis. Clin Neuropsychopharmacol 6:s9-s26
70. Tollefson GD, Beasley CM, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME (1997) Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 154:457-465
71. Trevitt JT, Lyons M, Aberman J, Carriero D, Finn M, Salamone JD (1997) Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function. Psychopharmacology 132:74-81
72. Trevitt JT, Atherton LA, Aberman J, Salamone JD (1998) Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function. Psychopharmacology 137:61-66
73. Weiss KJ, Ciraulo DA, Shader RI (1980) Physostigmine test in the rabbit syndrome and tardive dyskinesia. Am J Psychiatry 137:627-628
74. Wiley JL, Compton AD, Porter JH (1994) Differential effects of clozapine and pimozide on fixed-ratio responding during repeated dosing. Pharmacol Biochem Behav 48:253-257